Latin America Dna Diagnostics Market Size & Outlook
Global Market
Related Markets
Latin America dna diagnostics market highlights
- The Latin America dna diagnostics market generated a revenue of USD 402.3 million in 2024.
- The market is expected to grow at a CAGR of 8.6% from 2025 to 2030.
- In terms of segment, pcr-based diagnostics was the largest revenue generating technology in 2024.
- NGS DNA Diagnosis is the most lucrative technology segment registering the fastest growth during the forecast period.
- Country-wise, Brazil is expected to register the highest CAGR from 2025 to 2030.
Latin America data book summary
| Market revenue in 2024 | USD 402.3 million |
| Market revenue in 2030 | USD 660.8 million |
| Growth rate | 8.6% (CAGR from 2025 to 2030) |
| Largest segment | Pcr-based diagnostics |
| Fastest growing segment | NGS DNA Diagnosis |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | PCR-based Diagnostics, NGS DNA Diagnosis, In-Situ Hybridization Diagnostics, Microarrays-based Diagnostics, Other Technologies |
| Key market players worldwide | GE HealthCare Technologies Inc Common Stock, Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories Inc, Thermo Fisher Scientific Inc, Illumina Inc, Danaher Corp, Hologic Inc, Siemens Healthineers AG ADR, Roche, Qiagen NV, Agilent Technologies Inc |
Other key industry trends
- In terms of revenue, Latin America region accounted for 3.8% of the global dna diagnostics market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 4,851.6 million by 2030.
The Latin America DNA diagnostics market has witnessed significant growth in the past few years due to the increase in prevalence of various types of cancer in the region. Several surveys by various government and nonprofit organizations revealed that overall cancer mortality in Latin America is almost twice that of high-income countries.
Moreover, according to data published by the European Society for Medical Oncology, there have been approximately 1.5 million new cancer cases and 700,000 deaths reported in Latin America and the Caribbean region annually.
In the past few years, the region has witnessed rapid growth in cancer screening techniques, along with other cancer detection methods, due to increasing funding and execution of various cancer programs. Hence, the rising prevalence of chronic diseases and increased awareness about the importance of early cancer detection is leading to more people opting for DNA screening tests.
No credit card required*
Publish Date: Oct 14, 2025
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
DNA Diagnostics Market Scope
DNA Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| GE HealthCare Technologies Inc Common Stock | View profile | 51,000 | 500 West Monroe Street, Chicago, IL, United States, 60661 | www.gehealthcare.com |
| Abbott Laboratories | View profile | 114,000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | www.abbottinvestor.com |
| Siemens Healthineers AG ADR | View profile | 71,400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | www.siemens-healthineers.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
| Illumina Inc | View profile | 9,300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | www.illumina.com |
| Agilent Technologies Inc | View profile | 17,700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | www.agilent.com |
| Bio-Rad Laboratories Inc | View profile | 8,030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | www.bio-rad.com |
| Qiagen NV | View profile | 5,900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | www.qiagen.com |
| Hologic Inc | View profile | 6,990 | 250 Campus Drive, Marlborough, MA, United States, 01752 | www.hologic.com |
Latin America DNA Diagnostics Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to DNA Diagnostics Market Outlook will help companies and investors design strategic landscapes.
Pcr-Based Diagnostics was the largest segment with a revenue share of 52.57% in 2024.
Horizon Databook has segmented the Latin America dna diagnostics market based on pcr-based diagnostics, ngs dna diagnosis, in-situ hybridization diagnostics, microarrays-based diagnostics, other technologies covering the revenue growth of each sub-segment from 2018 to 2030.
The Latin America DNA diagnostics market has witnessed significant growth in the past few years due to the increase in prevalence of various types of cancer in the region. Several surveys by various government and nonprofit organizations revealed that overall cancer mortality in Latin America is almost twice that of high-income countries.
Moreover, according to data published by the European Society for Medical Oncology, there have been approximately 1.5 million new cancer cases and 700,000 deaths reported in Latin America and the Caribbean region annually.
In the past few years, the region has witnessed rapid growth in cancer screening techniques, along with other cancer detection methods, due to increasing funding and execution of various cancer programs. Hence, the rising prevalence of chronic diseases and increased awareness about the importance of early cancer detection is leading to more people opting for DNA screening tests.
- Latin America Dna Diagnostics Market Technology Outlook (Revenue, USD Million , 2018-2030)
- PCR-based Diagnostics
- NGS DNA Diagnosis
- In-Situ Hybridization Diagnostics
- Microarrays-based Diagnostics
- Other Technologies
- Latin America Dna Diagnostics Market Application Outlook (Revenue, USD Million , 2018-2030)
- Cancer Genetics Tests
- Infectious Diseases DNA Testing
- Newborn Genetic Screening
- Preimplantation & Reproductive Diagnosis
- Non-Infectious Diseases DNA Testing
- Prenatal DNA Carrier Screening
- Pharmacogenomics/Drug Metabolism
- Hematology & Immunology/Identity Diagnostics & Forensics
- Others
Reasons to subscribe to DNA Diagnostics Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of DNA Diagnostics Market Outlook databook
- Our clientele includes a mix of DNA Diagnostics Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America DNA Diagnostics Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Latin America DNA Diagnostics Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Latin America Dna Diagnostics Market, 2018-2030 (US$M)
Latin America dna diagnostics market statistics, by technology, 2018-2030 (US$M)
